GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now gaining a prominent focus in therapeutic investigation, largely due to its notable impact on treating ailments such as adult-onset diabetes and weight gain. Ongoing research have revealed that more than glucose management, GLP-1 drugs offer potential for cardiovascular health and… Read More